Artiva Biotherapeutics, Inc. (ARTV)
6.69
-0.14
(-2.05%)
USD |
NASDAQ |
Oct 05, 10:49
Artiva Biotherapeutics Market Cap : 326.42M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 333.25M |
| October 01, 2026 | 331.30M |
| September 30, 2026 | 347.40M |
| September 29, 2026 | 343.01M |
| September 28, 2026 | 343.99M |
| September 25, 2026 | 341.06M |
| September 24, 2026 | 365.45M |
| September 23, 2026 | 376.68M |
| September 22, 2026 | 394.73M |
| September 21, 2026 | 382.04M |
| September 18, 2026 | 420.10M |
| September 17, 2026 | 411.81M |
| September 16, 2026 | 419.61M |
| September 15, 2026 | 434.74M |
| September 14, 2026 | 494.75M |
| September 11, 2026 | 498.66M |
| September 10, 2026 | 508.42M |
| September 09, 2026 | 526.47M |
| September 08, 2026 | 530.86M |
| September 04, 2026 | 545.99M |
| September 03, 2026 | 542.81M |
| September 02, 2026 | 551.84M |
| September 01, 2026 | 550.38M |
| August 31, 2026 | 551.35M |
| August 28, 2026 | 541.11M |
| Date | Value |
|---|---|
| August 27, 2026 | 582.58M |
| August 26, 2026 | 574.29M |
| August 25, 2026 | 574.29M |
| August 24, 2026 | 562.09M |
| August 21, 2026 | 533.30M |
| August 20, 2026 | 543.55M |
| August 19, 2026 | 570.87M |
| August 18, 2026 | 569.89M |
| August 17, 2026 | 572.82M |
| August 14, 2026 | 558.67M |
| August 13, 2026 | 551.35M |
| August 12, 2026 | 562.58M |
| August 11, 2026 | 574.77M |
| August 10, 2026 | 547.45M |
| August 07, 2026 | 549.89M |
| August 06, 2026 | 565.01M |
| August 05, 2026 | 565.50M |
| August 04, 2026 | 540.13M |
| August 03, 2026 | 265.95M |
| July 31, 2026 | 249.64M |
| July 30, 2026 | 257.80M |
| July 29, 2026 | 247.66M |
| July 28, 2026 | 260.27M |
| July 27, 2026 | 255.08M |
| July 24, 2026 | 247.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Climb Bio, Inc. | 616.58M |
| Arrowhead Pharmaceuticals, Inc. | 8.811B |
| Oncolytics Biotech, Inc. | 72.36M |
| Sangamo Therapeutics, Inc. | 61.11M |
| Sarepta Therapeutics, Inc. | 1.818B |
Market Cap Related Metrics
| PEG Ratio | -0.2788 |
| Price to Book Value | 0.9393 |
| Price | 6.69 |
| Earnings Yield | -49.51% |
| PEGY Ratio | -0.2788 |